SCHEMBL26288487

SCHEMBL26288487

CCOC(=O)c1sc(I)nc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
CYP1A2 P05177 1/20 0.47
MAPT P10636 5/20 0.46
TRPM8 Q7Z2W7 4/20 0.46
MC4R P32245 1/20 0.45
HPGD P15428 4/20 0.44
LMNA P02545 1/20 0.44
PPARG P37231 1/20 0.43
NCOA2 Q15596 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
HSD17B10 Q99714 2/20 0.42
KDM4E B2RXH2 2/20 0.42
KMT2A Q03164 3/20 0.41
GAA P10253 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CDC7 O00311 2/20 0.41
DBF4 Q9UBU7 2/20 0.41
MEN1 O00255 2/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28049117 0.83 ALDH1A1 (0.50) ALDH1A1CYP1A2MAPTTRPM8MC4R
SCHEMBL3454027 0.83 ALDH1A1 (0.58) ALDH1A1CYP1A2MAPTHPGDLMNA
SCHEMBL23708646 0.81 ALDH1A1 (0.49) ALDH1A1CYP1A2MAPTTRPM8MC4R
SCHEMBL3332542 0.81 ALDH1A1 (0.66) ALDH1A1CYP1A2MAPTTRPM8MC4R
SCHEMBL26288504 0.81 MAPT (0.42) ALDH1A1MAPTTRPM8HPGDRXFP1
SCHEMBL23703077 0.80 ALDH1A1 (0.69) ALDH1A1CYP1A2MAPTTRPM8HPGD
SCHEMBL26281760 0.77 ALDH1A1 (0.47) ALDH1A1CYP1A2MAPTTRPM8HPGD
SCHEMBL20439915 0.77 ALDH1A1 (0.47) ALDH1A1CYP1A2MAPTTRPM8MC4R
SCHEMBL3454323 0.76 ALDH1A1 (0.51) ALDH1A1CYP1A2MAPTTRPM8MC4R
SCHEMBL5552417 0.76 ALDH1A1 (0.46) ALDH1A1CYP1A2MAPTTRPM8MC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors SIGNALRX PHARMACEUTICALS, INC. (US) 2023-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760762-B2 Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors CDK1, CDKN1A, CDKL1 ALDH1A1 3077/4885CYP1A2 2661/4885MAPT 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.